Innovative Product Launch FHC recently introduced the STarFix Designer software, which enhances pre-operative planning for neurosurgical procedures, representing a key opportunity for sales of advanced surgical planning tools and integrated software solutions.

Strategic Acquisitions The acquisition of Neuralynx and the subsequent launch of a dedicated Neuralynx website indicate expansion into neuroscience research tools, opening avenues for cross-selling and bundled offerings to research institutions.

Market Focus With a strong emphasis on neuromodulation therapies such as deep brain stimulation and movement disorder treatments, FHC's targeted product portfolio presents sales opportunities within clinical neuroscience departments and neuro-surgical centers.

Operational Adaptability The temporary office closures and remote work adaptations suggest resilience and flexibility in operations, providing an opportunity to engage with the company as they continue to innovate despite logistical challenges.

Growth Potential Operating in the $10M to $50M revenue bracket with a focus on customized solutions and a diverse product catalog, FHC is positioned for continued growth, making it an attractive prospect for expanding product partnerships and collaborative research funding.